Relationship Between Effect Duration of Rocuronium and Body Composition Analysis Data.
NCT ID: NCT05515835
Last Updated: 2023-01-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
88 participants
OBSERVATIONAL
2022-09-05
2023-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Abdominal Muscle Volume and a Neuromuscular Blocking Agent
NCT06769932
Skeletal Muscle Index and a Neuromuscular Blocking Agent
NCT06740877
Muscle Mass and Body Composition
NCT03184623
Changes in Skeletal Muscle Thickness in Patients With Acute Heart Failure
NCT06253104
Diagnosis of Muscular Weakness Syndrome After a Stay in Intensive Care : Measurement by Ultrasound
NCT03735693
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
rocuronium
The patient will be given 50mg of rocuronium intravenously for induction.
body composition analysis
Patients will undergo body composition analysis using bioelectical impedance method before anesthesia.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
body composition analysis
Patients will undergo body composition analysis using bioelectical impedance method before anesthesia.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* too underweight (under 41.67kg, which corresponds to more than 1.2mg/kg of induction dose of rocuronium)
* pregnancy
* prediagnosed muscle or nerve related disease
* unsuitable for body composition analysis using bioelectrical impedance method
* unsuitable for neuromuscular block monitoring
19 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Samsung Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jong Hwan Lee
Prof.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Samsung Medical Center, Sungkyunkwan University, School of Medicine
Seoul, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SMC 2022-07-160
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.